Publicaciones en colaboración con investigadores/as de Zhejiang Cancer Hospital (1)

2023

  1. Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

    ESMO Open, Vol. 8, Núm. 6